TIES | $1,500,000 | (Apr 30, 2026)
Parallel Web Systems | $100,000,000 | (Apr 30, 2026)
Lighthouse Pharmaceuticals | $12,000,000 | (Apr 29, 2026)
Certified by Founder
Lodge
Mozart Therapeutics, Inc
start up
United States
- Seattle, WA
- 08/06/2023
- Series A
- $25,000,000
Mozart is developing disease-modifying therapies for autoimmune and inflammatory diseases that work by targeting a novel regulatory immune pathway.
- Industry Biotechnology Research
- Website https://www.mozart-tx.com/
- LinkedIn https://www.linkedin.com/company/mozart-therapeutics/
IC Realtime | $2,000,000 | (Apr 29, 2026)
TrialClinIQ | $150,000 | (Apr 29, 2026)
Windmill(US) | $12,000,000 | (Apr 29, 2026)
Golden Child | $37,000,000 | (Apr 29, 2026)
Hypervision Surgical | $22,962,410 | (Apr 29, 2026)
dehaze | $3,746,192 | (Apr 29, 2026)
Clarasight | $11,500,000 | (Apr 29, 2026)
Liquid Instruments | $50,000,000 | (Apr 29, 2026)
HrFlow.ai | $7,000,000 | (Apr 28, 2026)